ישראל - עברית - Ministry of Health

zoetis israel holding b.v., israel - maropitant as citrate monohydrate - תמיסה להזרקה - maropitant as citrate monohydrate 10 mg/ml - in dogs above age 8 weeks and cats above age 16 weeks : for the prevention of vomiting except that induced by motion sickness.for the treatment of vomiting, in combination with other supportive measures.dogs age 8 - 10 weeks must be ander close medical supervision or hospitalized.

ישראל - עברית - Ministry of Health

zoetis israel holding b.v., israel - maropitant as citrate monohydrate - תמיסה להזרקה - maropitant as citrate monohydrate 10 mg/ml

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - maropitant as citrate monohydrate 24 mg - tablets - in dogs : for the prevention of vomiting including that induced by chemotherapy. for the treatment of vomiting, in conjunction with cerenia solution for infection and in combination with other supportive measures.for the prevention of vomiting induced by motion sickness.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - maropitant as citrate monohydrate 60 mg - tablets - in dogs : for the prevention of vomiting including that induced by chemotherapy. for the treatment of vomiting, in conjunction with cerenia solution for infection and in combination with other supportive measures.for the prevention of vomiting induced by motion sickness.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - maropitant as citrate monohydrate 16 mg - tablets - in dogs : for the prevention of vomiting including that induced by chemotherapy. for the treatment of vomiting, in conjunction with cerenia solution for infection and in combination with other supportive measures.for the prevention of vomiting induced by motion sickness.

ישראל - עברית - Ministry of Health

pfizer pharmaceuticals israel ltd - maropitant as citrate monohydrate 160 mg - tablets - in dogs : for the prevention of vomiting including that induced by chemotherapy. for the treatment of vomiting in conjunction with cerenia solution for injection and in combination with other supportive measures. for the prevention of vomiting induced by motion sickness.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

ישראל - עברית - Ministry of Health

merck sharp & dohme (israel - 1996) company ltd, israel - aprepitant - קפסולות - aprepitant 80 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.

ישראל - עברית - Ministry of Health

merck sharp & dohme israel ltd - aprepitant - קפסולות - aprepitant 125 mg - aprepitant - aprepitant - emend in combination with other antiemetic agents is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy including high-dose cisplatin. - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy.